No Data
No Data
Express News | Mabwell Announces Nmpa Approval to Initiate Clinical Trial of Novel B7-H3-Targeting ADC for Advanced Solid Tumors in Combination With Pd-1 Inhibitor
Maiwei Biotech: Maiwei Biotech 2024 Annual Report
Maiwei Biotech: Summary of Maiwei Biotech\'s 2024 Annual Report
Maiwei Biotech 2024 Annual Report
Maiwei Biotech 2024 Annual Report Summary
Maiwei Biotech (688062.SH) released its performance for the year 2024, with a net loss attributable to the parent company of 1.044 billion yuan, a reduction in losses.
Maiwei Bio (688062.SH) released the annual report for 2024, with the company's revenue for the fiscal year 2024 amounting to 1....